RecruitingPhase 2NCT05140148

Promoting Recovery After STroke With Amantadine

Studying Acute motor axonal neuropathy

Last synced from ClinicalTrials.gov May 2, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Pennsylvania
Intervention: Amantadine(drug)
Enrollment: 60 enrolled
Eligibility: 18-85 years · All sexes
Timeline: 2022 – 2028

Study locations (1)

The Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05140148 on ClinicalTrials.gov

Other trials for Acute motor axonal neuropathy

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT07421427
Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome
Cairo University
ACTIVE NOT RECRUITINGPHASE2NCT06253923
Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).
SHINKEI Therapeutics, Inc
RECRUITINGNCT05504057
Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection
Consorci Sanitari de Terrassa
RECRUITINGNCT04367883
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
Consorci Sanitari de Terrassa
ACTIVE NOT RECRUITINGPHASE2NCT06443827
Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness
Azienda Sanitaria dell'Alto Adige

See all trials for Acute motor axonal neuropathy →

← Back to all trials